首页> 外文期刊>Liver international >Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease
【24h】

Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease

机译:与铁调素耐药性相关的铁输出减少可以解释铁转运蛋白疾病中的铁过载谱

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Aims Ferroportin disease (FD) and hemochromatosis type 4 (HH4) are associated with variants in the ferroportin-encoding geneSLC40A1. Both phenotypes are characterized by iron overload despite being caused by distinct variants that either mediate reduced cellular iron export in FD or resistance against hepcidin-induced inactivation of ferroportin in HH4. The aim of this study was to assess if reduced iron export also confers hepcidin resistance and causes iron overload in FD associated with the R178Q variant. Methods The ferroportin disease variants R178Q andA77D and the HH4-variant C326Y were overexpressed in HEK-293T cells and subcellular localization was characterized by confocal microscopy and flow cytometry. Iron export and cytosolic ferritin were measured as markers of iron transport and radioligand binding studies were performed. The hepcidin-ferroportin axis was assessed by ferritin/hepcidin correlation in patients with different iron storage diseases. Results In the absence of hepcidin, the R178Q and A77D variants exported less iron when compared to normal and C326Y ferroportin. In the presence of hepcidin, the R178Q and C326Y, but not the A77D-variant, exported more iron than cells expressing normal ferroportin. Regression analysis of serum hepcidin and ferritin in patients with iron overload are compatible with hepcidin deficiency in HFE hemochromatosis and hepcidin resistance in R178Q FD. Conclusions These results support a novel concept that in certain FD variants reduced iron export and hepcidin resistance could be interlinked. Evasion of mutant ferroportin from hepcidin-mediated regulation could result in uncontrolled iron absorption and iron overload despite reduced transport function.
机译:背景和目的 铁转运蛋白病 (FD) 和 4 型血色素沉着症 (HH4) 与铁转运蛋白编码基因 SLC40A1 的变异有关。这两种表型的特征都是铁超载,尽管它们是由介导 FD 中细胞铁输出减少或对铁调素诱导的 HH4 中铁转运蛋白失活的不同变体引起的。本研究的目的是评估铁输出减少是否也会赋予铁调素耐药性并导致与 R178Q 变体相关的 FD 中的铁过载。方法 采用HEK-293T细胞过表达铁转运蛋白病变异株R178Q和A77D以及HH4变异株C326Y,采用共聚焦显微镜和流式细胞术对亚细胞定位进行表征。测量铁输出和胞质铁蛋白作为铁转运的标志物,并进行放射性配体结合研究。在不同铁贮积病患者中,通过铁蛋白/铁调素相关性评估铁调素-铁转运蛋白轴。结果 在没有铁调素的情况下,与正常和 C326Y 铁转运蛋白相比,R178Q 和 A77D 变体输出的铁更少。在铁调素存在的情况下,R178Q 和 C326Y(而不是 A77D 变体)输出的铁比表达正常铁转运蛋白的细胞更多。铁超负荷患者血清铁调素和铁蛋白的回归分析与 HFE 血色素沉着症中的铁调素缺乏症和 R178Q FD 中的铁调素耐药性相符。结论 这些结果支持了一个新概念,即在某些FD变体中,铁输出减少和铁调素耐药性可能相互关联。尽管转运功能降低,但铁调素介导的调节中逃避突变铁转运蛋白可能导致铁吸收不受控制和铁过载。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号